NASDAQ:BIOA
BioAge Labs, Inc.
BioAge Labs, Inc.'s revenue was $9.0M in fiscal 2025. Free cash flow was −$82.3M, −915.5% of revenue, and the diluted share count rose 235.0%.Summary generated from BioAge Labs, Inc.'s SEC filings. Latest annual report filed Mar 24, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$9.0M
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating margin−1031.5%
Net margin−896.1%
ROIC−232.4%
Return on equity−27.1%
Debt / equity0.01
Free cash flow−$82.3M
FCF margin−915.5%
Share count change+235.0%
Financials
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | n/a | 0 | 9 |
| Operating income | −48 | −78 | −93 |
| Net income | −64 | −71 | −81 |
| Free cash flow | −38 | −52 | −82 |
Recent filings
- 8-KOther events
Oct 2, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 5, 2026 - 8-KResults of operations and financial condition
Aug 5, 2026 - 4Insider transaction report
Jul 1, 2026 - 4Insider transaction report
Jun 12, 2026 - 8-KResults of a shareholder vote
Jun 12, 2026 - 8-KResults of operations and financial condition
May 8, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 8, 2026